We are live on ! Find out more
TBA

Train Babcock Advisors Portfolio holdings

AUM $227M
1-Year Est. Return 26.19%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+26.19%
3 Year Est. Return
+41.86%
5 Year Est. Return
10 Year Est. Return
AUM
$227M
AUM Growth
+$47.7M
Cap. Flow
+$34.2M
Cap. Flow %
15.08%
Top 10 Hldgs %
37.29%
Holding
115
New
29
Increased
3
Reduced
57
Closed
18

Top Sells

Rank Stock Value
1
HBI
Hanesbrands
HBI
+$3.07M
2
CNC icon
Centene
CNC
+$2.02M
3
ESRX
Express Scripts Holding Company
ESRX
+$1.73M
4
WBD icon
Warner Bros
WBD
+$1.38M
5
SLB icon
SLB Ltd
SLB
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 15.43%
2 Healthcare 10.12%
3 Financials 10.11%
4 Communication Services 9.21%
5 Industrials 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
51
State Street
STT
$50.9B
$1.02M 0.45%
10,436
-965
-8% -$92.2K
SDY icon
52
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$929K 0.41%
+9,832
New +$921K
FDN icon
53
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.86B
$912K 0.4%
+8,300
New +$892K
BBH icon
54
VanEck Biotech ETF
BBH
$396M
$902K 0.4%
+7,237
New +$924K
FTV icon
55
Fortive
FTV
$19B
$863K 0.38%
18,921
-1,096
-5% -$50.2K
BIDU icon
56
Baidu
BIDU
$35.8B
$839K 0.37%
3,582
-1,718
-32% -$420K
XBI icon
57
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$815K 0.36%
+9,595
New +$804K
XLV icon
58
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$797K 0.35%
+9,638
New +$795K
CVS icon
59
CVS Health
CVS
$137B
$755K 0.33%
10,414
-6,307
-38% -$459K
ABBV icon
60
AbbVie
ABBV
$458B
$704K 0.31%
7,285
-3,095
-30% -$292K
HD icon
61
Home Depot
HD
$332B
$668K 0.29%
3,523
-1,300
-27% -$224K
XLE icon
62
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$650K 0.29%
+18,000
New +$620K
AET
63
DELISTED
Aetna Inc
AET
$640K 0.28%
3,550
ITB icon
64
iShares US Home Construction ETF
ITB
$2.41B
$611K 0.27%
+13,984
New +$566K
MRK icon
65
Merck
MRK
$324B
$609K 0.27%
11,329
+1,871
+20% +$104K
IVOO icon
66
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
$540K 0.24%
+8,440
New +$527K
IYH icon
67
iShares US Healthcare ETF
IYH
$3.11B
$523K 0.23%
+15,000
New +$521K
IWS icon
68
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$508K 0.22%
+5,700
New +$495K
MMM icon
69
3M
MMM
$89B
$486K 0.21%
2,470
AVY icon
70
Avery Dennison
AVY
$12.3B
$454K 0.2%
3,950
-850
-18% -$91.9K
RDS.A
71
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$434K 0.19%
6,500
-2,300
-26% -$145K
KO icon
72
Coca-Cola
KO
$354B
$413K 0.18%
9,000
-1,600
-15% -$73.5K
PM icon
73
Philip Morris
PM
$301B
$410K 0.18%
3,878
-1,300
-25% -$139K
PYPL icon
74
PayPal
PYPL
$49.5B
$392K 0.17%
5,330
-110
-2% -$7.95K
VCR icon
75
Vanguard Consumer Discretionary ETF
VCR
$5.84B
$390K 0.17%
+2,500
New +$373K

Similar funds

Train Babcock Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Train Babcock Advisors held 115 positions worth $227M, up 27% from $179M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Train Babcock Advisors deployed $34.2M of net new capital in Q4 2017, opening 29 new positions and adding to 3 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 61,378 shares worth $16.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Centene, an estimated $2.02M trimmed.

  • Train Babcock Advisors's largest Q4 2017 buy was State Street SPDR S&P 500 ETF Trust: 61,378 shares worth $16.4M.
  • Train Babcock Advisors added most to Halliburton in Q4 2017, an estimated $724K increase.
  • Train Babcock Advisors's biggest Q4 2017 reduction was Centene, cutting an estimated $2.02M.
  • Train Babcock Advisors fully exited Hanesbrands in Q4 2017, selling an estimated $3.07M.
  • Train Babcock Advisors's ten largest holdings make up 37% of its $227M portfolio in Q4 2017.
  • Train Babcock Advisors opened 29 new positions and closed 18 in Q4 2017.
  • Train Babcock Advisors's portfolio value rose 27% quarter-over-quarter to $227M.

Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.